NCT02141061View on ClinicalTrials.gov

Comparison of Two Formulations of Proellex for Oral Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Healthy
Interventions
DRUG

Telapristone Acetate, Proellex 12 mg Formulation A

DRUG

Telapristone Acetate, Proellex 12 mg Formulation B

Trial Locations (1)

77030

Houston

All Listed Sponsors
lead

Repros Therapeutics Inc.

INDUSTRY

NCT02141061 - Comparison of Two Formulations of Proellex for Oral Administration | Biotech Hunter | Biotech Hunter